Related Experiment Video

Updated: Jul 5, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Vanadyl bisacetylacetonate induced G1/S cell cycle arrest via high-intensity ERK phosphorylation in HepG2 cells

Ying Fu1, Qin Wang, Xiao-Gai Yang

  • 1Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100083, People's Republic of China.

Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|May 17, 2008
PubMed

Insights

Vanadyl bisacetylacetonate ([VO(acac)(2)]) halts cancer cell growth by inducing G1 phase arrest in HepG2 cells. This anticancer effect involves the ERK signaling pathway, offering new insights into vanadium compounds for cancer therapy.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Vanadium compounds exhibit anticancer properties, but their mechanisms remain unclear.
  • Understanding these mechanisms is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To investigate the anticancer effects and underlying mechanisms of vanadyl bisacetylacetonate ([VO(acac)(2)]) in HepG2 cells.
  • To elucidate the role of cell cycle regulation and specific signaling pathways in [VO(acac)(2)]-induced proliferation inhibition.

Main Methods:

  • HepG2 cells were treated with varying doses and times of [VO(acac)(2)].
  • Cell cycle progression was analyzed using flow cytometry.
  • Protein levels and phosphorylation states of key cell cycle regulators (pRb, cyclins, p21) and signaling molecules (ERK, Akt) were assessed via Western blotting.
  • The role of the MEK/ERK pathway was investigated using the inhibitor U0126.

Main Results:

  • [VO(acac)(2)] induced a dose- and time-dependent G1 phase cell cycle arrest in HepG2 cells.
  • This arrest was associated with decreased phosphorylation of pRb and reduced expression of cyclin D1, E, and A, alongside increased p21 expression.
  • The treatment led to significant activation of phosphorylated ERK and Akt signaling pathways.
  • Inhibition of ERK signaling partially restored pRb phosphorylation and released the cell cycle arrest.

Conclusions:

  • [VO(acac)(2)] inhibits HepG2 cell proliferation by inducing G1/S cell cycle arrest.
  • This arrest is mediated by decreased pRb phosphorylation, influenced by the activated ERK signaling pathway.
  • These findings highlight the potential of [VO(acac)(2)] as an anticancer agent and provide mechanistic insights into its action.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization08:52

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization

Published on: August 16, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...